#COVID19 Promising study of a purified inactivated SARS-CoV-2 virus vaccine induced SARS-CoV-2-specific neutralizing antibodies in mice, rats and non-human primates.
These antibodies potently neutralized 10 representative SARS-CoV-2 strains.
Pre-print: https://www.biorxiv.org/content/10.1101/2020.04.17.046375v1">https://www.biorxiv.org/content/1...
These antibodies potently neutralized 10 representative SARS-CoV-2 strains.
Pre-print: https://www.biorxiv.org/content/10.1101/2020.04.17.046375v1">https://www.biorxiv.org/content/1...
Importantly, “Immunization with two different doses [of vaccine] (3 μg or 6 μg per dose) provided partial or complete protection in macaques against SARS-CoV-2 challenge, respectively, without any antibody-dependent enhancement of infection.” #COVID19
#COVID19 Here& #39;s more context from @ScienceMagazine on the study in this thread that showed a vaccine protecting a monkey from COVID-19 infection.
The vaccine (PiCoVacc) is being developed by a Chinese biotech (Sinovac) and is in Phase 1 trials (n=144). https://www.sciencemag.org/news/2020/04/covid-19-vaccine-protects-monkeys-new-coronavirus-chinese-biotech-reports">https://www.sciencemag.org/news/2020...
The vaccine (PiCoVacc) is being developed by a Chinese biotech (Sinovac) and is in Phase 1 trials (n=144). https://www.sciencemag.org/news/2020/04/covid-19-vaccine-protects-monkeys-new-coronavirus-chinese-biotech-reports">https://www.sciencemag.org/news/2020...